Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease. Cancer Res - Taipaleenmäki, H; Browne, G; Akech, J; Zustin, J; van Wijnen, A J; Stein, J L (2015)
et al.